Triple
T3767647
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Official Medicines Control Laboratories network |
E82717
|
entity |
| Predicate | hasPart |
P35
|
FINISHED |
| Object | Official Medicines Control Laboratory |
E82717
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Official Medicines Control Laboratory | Statement: [Official Medicines Control Laboratories network, hasPart, Official Medicines Control Laboratory]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Official Medicines Control Laboratory Context triple: [Official Medicines Control Laboratories network, hasPart, Official Medicines Control Laboratory]
-
A.
Official Medicines Control Laboratories network
chosen
The Official Medicines Control Laboratories network is a European system of public laboratories that independently test and verify the quality of medicines to support regulatory authorities and protect public health.
-
B.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
C.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
D.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
E.
Veterinary Medicines Directorate
The Veterinary Medicines Directorate is a UK government agency responsible for regulating veterinary medicines and ensuring their safety, quality, and effectiveness in animals and the food chain.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ad8b207b0081909d2b48843fbd8795 |
completed | March 8, 2026, 2:43 p.m. |
| NER | Named-entity recognition | batch_69adcc2bdf6c819088d3c6ace83ca5ea |
completed | March 8, 2026, 7:21 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69b4e5251d2481909f692937271a8013 |
completed | March 14, 2026, 4:33 a.m. |
Created at: March 8, 2026, 3:35 p.m.